These findings can help us in daily clinical practice, in predicting the percentage of weight loss and making a shared decision with the patient about whether to continue the new pill or move to the more traditional injection, Dr
Most individuals develop competence and confidence with injection technique within 2-3 administrations, with initial apprehension giving way to routine as the process becomes familiar
According to NICE Technology Appraisal 875 (TA875) , Wegovy (semaglutide) is available on the NHS only through specialist weight management services and for adults who meet specific criteria, including: Generally, a body mass index (BMI) of 35 kg/m or greater with weight-related comorbidities (with lower thresholds for certain ethnic groups) Referral to and engagement with a specialist weight management service (Tier 3) Treatment limited to a maximum of 2 years This differs from the broader marketing authorisation criteria in the SmPC, which includes adults with a BMI of 30 kg/m or greater, or 27 kg/m or greater with weight-related comorbidities
By January this year, I was at 200lbs again
Should clinicians prescribe GLP-1 medications for Parkinsons disease now
Most patients see their first measurable weight loss between Week 2 and Week 4, with an average of 15 pounds by the end of the first month
